Break It Up: FTC Files Antitrust Action Against Big Pharma Companies
By EsqSocial Corporation 03/02/21
On January 25, 2021, just weeks after Congress directed the Federal Trade Commission (FTC) to scrutinize the healthcare industry for anti-competitive activity, the FTC filed a meticulously detailed complaint against Endo Pharamceuticals, Inc. and Impax Laboratories, LLC in the District Court for the District of Columbia, alleging that the defendants obtained an unlawful monopoly on the opioid drug oxymorphone ER....
By: Arnall Golden Gregory LLP